Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...

We caught up with Robert Fan, the SVP of Global Sales at Silicon Motion, as part of our promotional coverage for Embedded World 2025. He discusses Silicon Motion unveiling its latest storage and ...